Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benchmarking community drug response prediction models: datasets, models, tools, and metrics for cross-dataset generalization analysis.

Briefings in bioinformatics·2026
Same author

Combining compositional data sets introduces error in covariance network reconstruction.

ISME communications·2024
Same author

Inferring microbial interactions with their environment from genomic and metagenomic data.

PLoS computational biology·2023
Same author

Characterization and Optimization of Multiomic Single-Cell Epigenomic Profiling.

Genes·2023
Same author

Human kidney stones: a natural record of universal biomineralization.

Nature reviews. Urology·2021
Same author

Predominance of Atopobium vaginae at Midtrimester: a Potential Indicator of Preterm Birth Risk in a Nigerian Cohort.

mSphere·2021

Related Experiment Video

Updated: Jun 25, 2026

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

11.6K

Metabolic model-based ecological modeling for probiotic design.

James D Brunner1,2, Nicholas Chia3

  • 1Biosciences Division, Los Alamos National Laboratory, Los Alamos, United States.

Elife
|February 21, 2024
PubMed
Summary
This summary is machine-generated.

Understanding gut microbiome therapies is key for health. This study uses metabolic modeling to predict probiotic success by analyzing microbe interactions, revealing factors driving engraftment.

Keywords:
B. longumC. difficileL. plantarumcomputational biologygenome-scale metabolic modelingmicrobiomeprobioticssystems biology

More Related Videos

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.6K
Bioreactor Assembly for Continuous Culture of Complex Fecal Communities
09:37

Bioreactor Assembly for Continuous Culture of Complex Fecal Communities

Published on: April 25, 2025

318

Related Experiment Videos

Last Updated: Jun 25, 2026

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

11.6K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.6K
Bioreactor Assembly for Continuous Culture of Complex Fecal Communities
09:37

Bioreactor Assembly for Continuous Culture of Complex Fecal Communities

Published on: April 25, 2025

318

Area of Science:

  • Microbiology
  • Systems Biology
  • Computational Biology

Background:

  • Human gut microbial composition significantly impacts health.
  • Microbiome therapies, including probiotics, are widely used but their success factors are unclear.
  • Investigating biotic interactions is crucial for understanding treatment efficacy.

Purpose of the Study:

  • To investigate the biotic interactions influencing the engraftment of novel bacterial strains in the gut microbiome.
  • To develop a predictive model for the success of microbiome-targeted treatments.
  • To identify specific microbe-microbe interactions driving successful probiotic engraftment.

Main Methods:

  • Utilized pairwise genome-scale metabolic modeling to construct interaction networks.
  • Employed a generalized resource allocation constraint for modeling.
  • Applied induced sub-graphs and a generalized Lotka-Volterra model to assess engraftment likelihood based on network structure.

Main Results:

  • The generalized Lotka-Volterra model demonstrated a strong ability to predict the successful engraftment of bacterial invaders and probiotics.
  • Network structure analysis was effective in assessing the probability of invader engraftment.
  • The mechanistic model successfully identified key microbe-microbe interactions contributing to engraftment.

Conclusions:

  • Microbe-microbe interactions within the gut microbiome network are critical determinants of probiotic treatment success.
  • Predictive modeling based on metabolic interactions can forecast the efficacy of microbiome therapies.
  • Understanding these interactions offers mechanistic insights into microbiome engraftment and therapeutic outcomes.